GenScript ProBio
Business Services · New Jersey, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
20 Kingsbridge Rd, Piscataway, New Jerse...Phone Number
(732) 885-9188Website
www.genscriptprobio.cnRevenue
$71.5 MillionIndustry
About GenScript ProBio
GenScript ProBio Org Chart
Is GenScript ProBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on GenScript ProBio recently announced quarterly report
Product Launch: Get notified when GenScript ProBio launches new products
Click to see if GenScript ProBio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once GenScript ProBio has new funding data
Congratulate Masked Content for being promoted to Masked Content at GenScript ProBio
Check out if GenScript ProBio is spiking on competitors!
Check if GenScript ProBio has recently received funding, and reach out quickly before it becomes old news!
GenScript ProBio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined GenScript ProBio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
GenScript ProBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GenScript ProBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GenScript ProBio.
GenScript ProBio financials insights
Gather financial insights about GenScript ProBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series C
$220M
GenScript ProBio Tech Stack
A closer look at the technologies used by GenScript ProBio
Most Recent Scoops
GenScript ProBio News & Media
GenScript ProBio Partners With NuclixBio to Pave the Way for South Korea’s First Large-scale Production Process for “Circular RNA Therapeutics”
SEOUL, Korea--(BUSINESS WIRE)--GenScript ProBio, a global multimodality CDMO and NuclixBio, a company developing treatments based on circular RNA, announced on 9th Nov that they have entered into a strategic business agreement to develop the first circular RNA-based anticancer drug in South Korea. With this strategic partnership, both companies will establish the first large-scale production process for circular RNA therapeutics in South Korea from preclinical to clinical stages (with GMP produGenScript ProBio Congratulates ABL Bio's IND Clearance of ABL103 Program from MFDS
SEOUL, South Korea, Oct. 13, 2023 /PRNewswire/ -- Recently, ABL Bio, a partner of GenScript ProBio, announced the Ministry of Food and Drug Safety (MFDS) cleared of its clinical trial application for innovative bispecific antibody program (B7H4x4-1BB) in solid tumor. GenScript ProBio warmly extends congratulations on this major milestone achievement. In this ABL103 program, GenScript ProBio provided the service of process development & optimization, clinical material manufacturing, and CTD documGenScript ProBio and Comprehensive Cell Solutions, a Business Unit of the New York Blood Center Enterprises, Form a Pioneering Partnership to Expedite Cell and Gene Therapy Development and Manufacturing
PISCATAWAY, N.J. & NEW YORK--(BUSINESS WIRE)--GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy development and manufacturing, have partnered to spearhead the development of cell and gene therapies, offering a unique and seamlessly integrated solution that spans cell collections and apheresis through cryopreservation of final therapeutics. The partnership’s core goal is to accelerate the development oGenScript ProBio Congratulates Eutilex's IND Clearance from MFDS
NANJING, China, March 7, 2023 /PRNewswire/ -- Recently, Eutilex, a partner of GenScript ProBio, announced MFDS (Ministry of Food and Drug Safety) clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T program (EU307). GenScript ProBio extends congratulations on this. 2 years ago, GenScript ProBio and Eutilex announced that the parties entered into strategic collaboration on plasmid and virus process development and manufacturing for multiple CAR-T programs. EU3
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GenScript ProBio
GenScript ProBio is a company that operates in the Research & Development industry. It employs 1000to4999 people and has 50Mto100M of revenue. The company is headquartered in Piscataway, New Jersey.... Read More